CD44 and glioblastoma: Studies have shown that EVs derived from the serum of glioblastoma patients exhibit upregulated levels of specific proteins such as C1QA, CD29, CD44, CD81, and CD146, as well as histone H3 compared to EVs from healthy individuals.